Looks promising but “We plan to create and validate monoclonal antibodies against misfolded TDP43 to select optimal therapeutic candidates for advancement into the clinic."
Do they have any compound identified to target it?
It is clearly gambling stock as any pre-climical work is miles away
Market Data 
Markets 
